The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Progress towards elimination goals for viral hepatitis
Andrea L Cox1, Manal H El-Sayed2, Jia-Horng Kao34, Jeffrey V Lazarus5, Maud Lemoine6, Anna S Lok7, Fabien Zoulim8910
Author information
1Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. acox@jhmi.edu.
2Department of Paediatrics, Ain Shams University, Cairo, Egypt. manalhelsayed@yahoo.co.uk.
3Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. kaojh@ntu.edu.tw.
4Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. kaojh@ntu.edu.tw.
5Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. Jeffrey.Lazarus@isglobal.org.
6Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Hepatology section, Imperial College London, St Mary's Hospital, London, UK. m.lemoine@imperial.ac.uk.
7Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. aslok@med.umich.edu.
8Medical School, Lyon University, Lyon, France. fabien.zoulim@inserm.fr.
9Hepatology Department, Hospices Civils de Lyon, Lyon, France. fabien.zoulim@inserm.fr.
10Viral Hepatitis Research Laboratory, CRCL - INSERM U1052, Lyon, France. fabien.zoulim@inserm.fr.
Abstract
The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top four global infectious diseases. In 2016, the 194 Member States of the World Health Organization committed to eliminating viral hepatitis as a public health threat by 2030, with a particular focus on hepatitis B virus and hepatitis C virus infection. With only 10 years to go until the 2030 deadline is reached, and although much progress has been made towards elimination, there are still some important gaps in terms of policy and progress. In this Viewpoint, we asked a selection of scientists and clinicians working in the viral hepatitis field for their opinions on whether elimination of viral hepatitis by 2030 is feasible, what the key areas of progress are and what the focus for the next 10 years and beyond should be for viral hepatitis elimination.